Cargando…

Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia

PURPOSE: Hyperuricemia carries an increased risk of atherothrombotic events in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). This may at least in part be due to inadequate P2Y12 inhibition. The aim of this study was to prospectively investigate the poten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Silvia, Wadowski, Patricia P., Hoberstorfer, Timothy, Weikert, Constantin, Pultar, Joseph, Kopp, Christoph W., Panzer, Simon, Gremmel, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808981/ https://www.ncbi.nlm.nih.gov/pubmed/32845391 http://dx.doi.org/10.1007/s10557-020-07058-x

Ejemplares similares

Platelet-to-lymphocyte and Neutrophil-to-lymphocyte Ratios Predict Target Vessel Restenosis after Infrainguinal Angioplasty with Stent Implantation
por: Lee, Silvia, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
por: Tscharre, Maximilian, et al.
Publicado: (2020)

Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes
por: Wadowski, Patricia P., et al.
Publicado: (2020)

Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome
por: Mutschlechner, David, et al.
Publicado: (2023)

Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y(12) inhibitors
por: Wadowski, Patricia P., et al.
Publicado: (2019)

Comparison of Light Transmission Aggregometry With Impedance Aggregometry in Patients on Potent P2Y12 Inhibitors
por: Wadowski, Patricia P., et al.
Publicado: (2020)

Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy
por: Wadowski, Patricia P., et al.
Publicado: (2017)

Protease‐activated receptor‐mediated platelet aggregation in patients with type 2 diabetes on potent P2Y (12) inhibitors
por: Panzer, Benjamin, et al.
Publicado: (2022)

Microvascular Thrombosis as a Critical Factor in Severe COVID-19
por: Wadowski, Patricia P., et al.
Publicado: (2023)

Functional capillary impairment in patients with ventricular assist devices
por: Wadowski, Patricia P., et al.
Publicado: (2019)

Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents
por: Testa, L., et al.
Publicado: (2010)

Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review
por: Panzer, Benjamin, et al.
Publicado: (2023)

Plasma Levels of snoRNAs are Associated with Platelet Activation in Patients with Peripheral Artery Disease
por: Nossent, Anne Yaël, et al.
Publicado: (2019)

Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices
por: Tscharre, Maximilian, et al.
Publicado: (2022)

Interleukin-6 and Asymmetric Dimethylarginine Are Associated with Platelet Activation after Percutaneous Angioplasty with Stent Implantation
por: Gremmel, Thomas, et al.
Publicado: (2015)

Impaired glucose metabolism is associated with increased thrombin generation potential in patients undergoing angioplasty and stenting
por: Lee, Silvia, et al.
Publicado: (2018)

Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy
por: Gremmel, Thomas, et al.
Publicado: (2015)

Glycocalyx as Possible Limiting Factor in COVID-19
por: Wadowski, Patricia P., et al.
Publicado: (2021)

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
por: Stojkovic, Stefan, et al.
Publicado: (2020)

Surrogate Markers of Neutrophil Extracellular Trap Formation are Associated with Ischemic Outcomes and Platelet Activation after Peripheral Angioplasty and Stenting
por: Demyanets, Svitlana, et al.
Publicado: (2020)

Synthesis, Docking Studies, and In Vitro Evaluation of Some Novel Thienopyridines and Fused Thienopyridine–Quinolines as Antibacterial Agents and DNA Gyrase Inhibitors
por: Mohi El-Deen, Eman M., et al.
Publicado: (2019)

A thienopyridine, CB-20, exerts diuretic activity by inhibiting urea transporters
por: Li, Min, et al.
Publicado: (2019)

Highly productive and scalable approach to synthesize ticlopidine: A potent thienopyridine anti-platelet aggregation drug
por: Faisal, Muhammad, et al.
Publicado: (2020)

Platelet inhibitory activity, tolerability, and safety of vicagrel, a novel thienopyridine P2Y12 inhibitor
por: Li, Hui, et al.
Publicado: (2020)

Switching between thienopyridines in patients with acute myocardial infarction and quality of care
por: Schiele, Francois, et al.
Publicado: (2016)

Micro- and Macrovascular Effects of Inflammation in Peripheral Artery Disease—Pathophysiology and Translational Therapeutic Approaches
por: Poledniczek, Michael, et al.
Publicado: (2023)

Tailored Thienopyridine Therapy: No Urgency for CYP2C19 Genotyping
por: Fontana, Pierre, et al.
Publicado: (2013)

A Simple Synthesis of Some New Thienopyridine and Thieno-pyrimidine Derivatives
por: El-Saghier, Ahmed M. M.
Publicado: (2002)

Is platelet inhibition due to thienopyridines increased in elderly patients, in patients with previous stroke and patients with low body weight as a possible explanation of an increased bleeding risk?
por: Breet, N. J., et al.
Publicado: (2011)

Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
por: Kiebist, Jan, et al.
Publicado: (2021)

Quantum mechanics and 3D-QSAR studies on thienopyridine analogues: inhibitors of IKKβ
por: Ul-Haq, Zaheer, et al.
Publicado: (2020)

Accessing the Ene–Imine Motif in 1H-Isoindole, Thienopyrrole, and Thienopyridine Building Blocks
por: Fillmore, Brandon C., et al.
Publicado: (2020)

α-Hydroxybutyrate dehydrogenase is associated with atherothrombotic events following infrainguinal angioplasty and stenting
por: Lee, Silvia, et al.
Publicado: (2019)

Continuous Use of Thienopyridine May Be as Safe as Low-Dose Aspirin in Endoscopic Resection of Gastric Tumors
por: Oh, Sooyeon, et al.
Publicado: (2018)

Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model
por: Mah-Becherel, M C M, et al.
Publicado: (2002)

Synthesis of a Novel Series of Amino Acid Prodrugs Based on Thienopyridine Scaffolds and Evaluation of Their Antiplatelet Activity
por: Lu, Nan, et al.
Publicado: (2018)

Is it possible to perform gastric endoscopic submucosal dissection without discontinuation of a single antiplatelet of thienopyridine derivatives?
por: Ono, Satoshi, et al.
Publicado: (2017)

Cold Snare Polypectomy in Patients Taking Dual Antiplatelet Therapy: A Randomized Trial of Discontinuation of Thienopyridines
por: Won Ma, Dae, et al.
Publicado: (2019)

Development of Thermo- and pH-Sensitive Liposomal Magnetic Carriers for New Potential Antitumor Thienopyridine Derivatives
por: Ribeiro, Beatriz C., et al.
Publicado: (2022)

Magnetoliposomes Containing Multicore Nanoparticles and a New Antitumor Thienopyridine Compound with Potential Application in Chemo/Thermotherapy
por: Lopes, Fábio A. C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r53uiqvjl83843ef39rm8vm5lt